Vaccine Adjuvants Market Size Forecast to Reach $1.67 Billion by 2025

October 7, 2020

Vaccine Adjuvants Market size is forecast to reach $1.67 billion by 2025, growing at a CAGR of 8.24% during the forecast period 2020-2025. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. Aluminum adjuvants are used in vaccines such as hepatitis A, hepatitis B, diphtheria and tetanus-containing vaccines. Protection via donated antibodies is short-lived, whereas protection via the tetanus shot lasts 10 years or more. Immunologic adjuvants are often used to modify or augment the effects of a vaccine by stimulating the immune system to respond to the vaccine more vigorously, and thus providing increased immunity to a particular disease. Immunostimulants and adjuvants can be administered before, with, or after vaccines to amplify the specific immune response generating elevations of circulating antibody titers and numbers of plaque-forming cells. Rapidly increasing incidences of various diseases among the masses, increasing demand for improved vaccine treatments, increasing R&D activities and investments, and government investments for providing vaccine dosage to the people are driving the market growth in recent years.

Key Takeaways

North America dominated the Vaccine Adjuvants Market in the year 2019 owing to increasing demand for improved medical results from vaccines, widespread transmission of coronavirus, growing prevalence of infectious diseases and increasing government investments for improvements in healthcare sector. The Vaccine Adjuvants Market scope for different regions will be provided in the final report.

Growing prevalence of infectious and chronic diseases in the last decade, increasing investments in R&D activities of vaccine, demand for vaccine of novel coronavirus (COVID-19) and increasing government expenditure for vaccine awareness programs have helped in significant growth of Vaccine Adjuvants Market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Vaccine Adjuvants Market report.

Higher costs of adjuvant vaccine products are anticipated to hamper the market growth of the Vaccine Adjuvants Industry.

Request for Sample of the Report @

Drivers – Vaccine Adjuvants Market

Growing prevalence of infectious and chronic diseases

Increasing government expenditure for vaccine awareness programs

Vaccine Adjuvants Industry Outlook

Vaccine Adjuvants Market top 10 companies are Brenntag Biosector A/S, Seppic, Seqirus, Agenus, Inc., Novavax, Inc., Invivogen, SPI Pharma, Inc., Avanti Polar Lipids, Inc., MVP Laboratories, Inc. and OZ Biosciences among others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.

Article Categories:

Leave a Comment